Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1218683/000121390018014440/f8k102418_wizepharmainc.htm
March 2021
March 2021
February 2021
February 2021
February 2021
January 2021
January 2021
December 2020
December 2020
December 2020
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1218683/000121390018014440/f8k102418_wizepharmainc.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Wize Pharma, Inc..
Wize Pharma, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Wize Pharma, Inc. provided additional information to their SEC Filing as exhibits
Ticker: WIZPEvents:
CIK: 1218683
Form Type: 8-K Corporate News
Accession Number: 0001213900-18-014440
Submitted to the SEC: Thu Oct 25 2018 8:20:23 AM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Wednesday, October 24, 2018
Industry: Pharmaceutical Preparations